Literature DB >> 12444112

NK cell CD94/NKG2A inhibitory receptors are internalized and recycle independently of inhibitory signaling processes.

Francisco Borrego1, Juraj Kabat, Tolib B Sanni, John E Coligan.   

Abstract

Human CD94/NKG2A is an inhibitory receptor that recognizes HLA-E and is expressed by NK cells and a subset of T cells. We have analyzed the cellular trafficking of the CD94/NKG2A receptor using the NKL cell line and peripheral blood NK cells. Flow cytometric, confocal microscopic, and biochemical analyses show that CD94/NKG2A continuously recycles in an active process that requires the cytoskeleton between the cell surface and intracellular compartments that are distinguishable from recycling compartments used by well-characterized receptors, such as transferrin receptor (CD71). CD94/NKG2A, an inhibitory receptor, traffics differently from the closely related CD94/NKG2C molecule, an activating receptor. Using transfection/expression analyses of wild-type and mutant CD94/NKG2A molecules in the HLA-E negative rat basophilic cell line RBL-2H3, we demonstrate that CD94/NKG2A internalization is independent of ligand cross-linking or the presence of functional immunoreceptor tyrosine-based inhibition motifs. Thus, the mechanisms that control cell surface homeostasis of CD94/NKG2A are independent of functional signaling.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12444112     DOI: 10.4049/jimmunol.169.11.6102

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Exclusion of lipid rafts and decreased mobility of CD94/NKG2A receptors at the inhibitory NK cell synapse.

Authors:  Tolib B Sanni; Madhan Masilamani; Juraj Kabat; John E Coligan; Francisco Borrego
Journal:  Mol Biol Cell       Date:  2004-05-07       Impact factor: 4.138

Review 2.  The CD94/NKG2 family of receptors: from molecules and cells to clinical relevance.

Authors:  Francisco Borrego; Madhan Masilamani; Alina I Marusina; Xiaobin Tang; John E Coligan
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  NKG2A and CD56 are coexpressed on activated TH2 but not TH1 lymphocytes.

Authors:  Robert J Freishtat; Lindsay W Mitchell; Svetlana D Ghimbovschi; Samuel B Meyers; Eric P Hoffman
Journal:  Hum Immunol       Date:  2006-03-27       Impact factor: 2.850

4.  Simian Immunodeficiency Virus Infection Modulates CD94+ (KLRD1+) NK Cells in Rhesus Macaques.

Authors:  Daniel R Ram; Olivier Lucar; Brady Hueber; R Keith Reeves
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

5.  Interactions of NK cell receptor KIR3DL1*004 with chaperones and conformation-specific antibody reveal a functional folded state as well as predominant intracellular retention.

Authors:  Sabrina B Taner; Marcelo J Pando; Allison Roberts; Jennifer Schellekens; Steven G E Marsh; Karl-Johan Malmberg; Peter Parham; Frances M Brodsky
Journal:  J Immunol       Date:  2010-11-29       Impact factor: 5.422

6.  NKG2A is a marker for acquisition of regulatory function by human CD8+ T cells activated with anti-CD3 antibody.

Authors:  Vitaly Ablamunits; Octavian Henegariu; Paula Preston-Hurlburt; Kevan C Herold
Journal:  Eur J Immunol       Date:  2011-06-06       Impact factor: 5.532

7.  Dissection of spontaneous cytotoxicity by human intestinal intraepithelial lymphocytes: MIC on colon cancer triggers NKG2D-mediated lysis through Fas ligand.

Authors:  Ellen C Ebert; Veronika Groh
Journal:  Immunology       Date:  2008-02-13       Impact factor: 7.397

8.  Altered coexpression of lectin-like receptors CD94 and CD161 on NK and T cells in HIV patients.

Authors:  Roland Jacobs; Klaus Weber; Katy Wendt; Hans Heiken; Reinhold E Schmidt
Journal:  J Clin Immunol       Date:  2004-05       Impact factor: 8.317

Review 9.  Endocytosis and intracellular trafficking of human natural killer cell receptors.

Authors:  Madhan Masilamani; Giovanna Peruzzi; Francisco Borrego; John E Coligan
Journal:  Traffic       Date:  2009-08-05       Impact factor: 6.215

Review 10.  Immunoregulatory cells for transplantation tolerance and graft-versus-leukemia effect.

Authors:  Masahiro Imamura; Junji Tanaka
Journal:  Int J Hematol       Date:  2003-10       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.